1. Home
  2. BGIN vs ANIK Comparison

BGIN vs ANIK Comparison

Compare BGIN & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BGIN

Bgin Blockchain Limited Class A Ordinary Shares

N/A

Current Price

$1.90

Market Cap

237.6M

Sector

N/A

ML Signal

N/A

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$20.74

Market Cap

200.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGIN
ANIK
Founded
2019
1983
Country
Singapore
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
237.6M
200.9M
IPO Year
2022
1996

Fundamental Metrics

Financial Performance
Metric
BGIN
ANIK
Price
$1.90
$20.74
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$17.00
AVG Volume (30 Days)
4.5K
71.4K
Earning Date
04-24-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.16
EPS
N/A
N/A
Revenue
N/A
$112,819,000.00
Revenue This Year
N/A
$5.98
Revenue Next Year
N/A
$7.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.61
$8.67
52 Week High
$5.19
$22.88

Technical Indicators

Market Signals
Indicator
BGIN
ANIK
Relative Strength Index (RSI) 43.55 51.92
Support Level $1.68 $20.13
Resistance Level $2.09 $22.70
Average True Range (ATR) 0.12 0.65
MACD -0.02 -0.18
Stochastic Oscillator 15.00 42.48

Price Performance

Historical Comparison
BGIN
ANIK

About BGIN Bgin Blockchain Limited Class A Ordinary Shares

BGIN Blockchain Ltd is a digital asset technology company engaged in cryptocurrency mining technologies, self-mining operations, and the design and sale of ASIC mining machines. The company develops proprietary mining hardware under its ICERIVER brand and provides mining infrastructure and hosting solutions. It operates through two reportable segments: cryptocurrency mining and sale of mining machines. The company focuses on cryptocurrencies such as Bitcoin, Dogecoin, KAS, ALPH, and RXD. Geographically, it derives revenue from Hong Kong, China, Vietnam, the United States, Singapore, and other markets.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: